-
Product Insights
Scape Grp/ Transnational Properties – 2 Charlesgate West Residential Complex – Massachusetts
Equip yourself with the essential tools needed to make informed and profitable decisions with our Scape Grp/ Transnational Properties - 2 Charlesgate West Residential Complex - Massachusetts report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Company Profile
Ecobank Transnational Inc – Company Profile
Ecobank Transnational Inc (Ecobank Group) is a banking and financial services group. The group offers a wide range of banking, consumer and commercial finance, investments, asset management, and securities services to financial institutions, government agencies, international organizations, multinationals, small, medium, and micro businesses, and individual customers. Its product portfolio comprises accounts and deposits which include savings, diaspora, and current accounts; card products that consist of credit cards and debit cards; lending solutions which comprise of loans for personal usage, mortgage,...
Add to Basket -
Thematic Analysis
Manned-Unmanned Teaming (MUM-T) – Thematic Intelligence
Manned-Unmanned Teaming (MUM-T) Thematic Intelligence Report Overview Manned-Unmanned Teaming (MUM-T) denotes the homogenous employment of heterogenous aerial assets, namely traditional manned platforms, and unmanned platforms, within individual combat units. The MUM-T concept seeks to enable human operators leverage the inherent benefits of both manned and unmanned platforms simultaneously, thus creating a multi-role and adaptive airborne force. The US and various other militaries have already begun testing the pairing of various unmanned assets with different types of fixed-wing and rotary-wing aircraft....
-
Company Profile
iFlytek Co Ltd – Company Profile
iFlytek Co Ltd (iFlytek) operates as an information technology company that develops speech technology, software, and chip products and services. The company's product portfolio comprises jarvisen translator, iFLYREC intelligent conference system, jingle magic, global chinese learning platform and an artificial intelligence outbound system. iFlytek provides payment and stolen card inquiries, self-study solutions, and internet system infrastructure solutions. It conducts technological research in speech and languages, machine learning, natural language understanding, machine reasoning, and adaptive learning. The company's intelligent conference system...
Add to Basket -
Sector Analysis
European Reliance on Russian Gas and Shift to LNG – Overview, Challenges and Case Studies
European Reliance on Russian Gas Shift to LNG Report Overview The European natural gas demand is expected to reach more than 440 bcm in 2030. This represents a negative CAGR rate of more than 5% between 2022 and 2030. This negative growth reflects the region’s shift away from natural gas as it diversifies its energy mix. However, despite this drop, demand will continue to exceed supply. Most of the demand will be met by domestic supply. Due to its reliance...
-
Product Insights
Cachexia Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Cachexia Global Clinical Trials Review, H2, 2016" provides an overview of Cachexia clinical trials scenario. This report provides top line data relating to the clinical trials on Cachexia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2016
GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H2, 2016" provides an overview of Obstructive Pulmonary Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Pulmonary Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Sector Analysis
Nigeria Wealth Report 2016
This report is the result of extensive research covering the high net worth individual (HNWI) population and wealth management market in Nigeria. In addition to an overview of the size of the local wealth management industry, the report also reviews the performance and asset allocations of HNWIs and ultra-high net worth individuals (UHNWIs). Furthermore, the analysis also includes insight on the development, challenges and opportunities for participants in the wealth management and private banking sector in Nigeria.
-
Product Insights
Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Peripheral Neuropathic Pain Global Clinical Trials Review, H1, 2016" provides an overview of Peripheral Neuropathic Pain clinical trials scenario. This report provides top line data relating to the clinical trials on Peripheral Neuropathic Pain. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2016
GlobalData's clinical trial report, “Obstructive Pulmonary Disease Global Clinical Trials Review, H1, 2016" provides an overview of Obstructive Pulmonary Disease clinical trials scenario. This report provides top line data relating to the clinical trials on Obstructive Pulmonary Disease. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...